Transgenic Service made in Switzerland
What we do
mouse models
client institutes
successful projects
How we do it
The Swiss way! You expect quality, and you are entitled to it. We will have sleepless nights if anything doesn’t run smoothly, and we can’t be satisfied if you as a customer are not perfectly happy. Our business is tricky – we know that acting wisely, quickly, and decidedly is what we are called upon constantly, any day: with highest quality infrastructure and best-educated staff. And since we’re efficient, we can also beat low prices.
And of course, we know that just as much as good science, our business is also excellent communication and good relationships to scientists and colleagues.
Why we do it
A point mutation in a heart-relevant gene seems to be linked to arrhythmia – can we confirm this in a mouse model? Within a patient study, an overexpressed gene is found to be linked to cancer – does suppressing it prevent a mouse from getting cancer?
Well-designed mouse models give clear-cut explanations, validate targets in the pharma discovery process, or hypotheses in academic research, and deliver surprising and novel insights that would not be possible otherwise.
Generating them: this is profoundly ethical, deeply complex and interesting, greatly captivating, and fundamentally relevant.
We share your fervor and engagement and are proud to partake in your research!
News
- Let’s meet at the next Horizon 2020 Health Brokerage Event in Oslo July 18, 2018
An updated version of the 2019 Horizon 2020 Societal Challenge 1 program has just been published by the European Commission. PolyGene, a very active and experienced EU project partner, is searching for consortia to join. We will present our services and collaboration opportunities at the Brokerage for Health event on the 3th and 4th of ...
» read more - Great news for PolyGene and collaborators under the same purpose October 2, 2017
PolyGene AG, together with TargetEx Kft. (Hungary), Intelligent Pharma (Spain) and University of Zürich (Switzerland), received European funding to continue PolyGene’s ambitious research program on gene regulation tools, and to successfully bring these expression systems to the market.
SwitchItOn will generate a toolbox of novel genomic switches, opening new avenues of ...
» read more